Beijing Foyou Pharma (601089.SH): Minoxidil topical solution received drug registration certificate.
Fuyuan Pharmaceuticals (601089.SH) announced that recently, its wholly-owned subsidiary Fuyuan Pharmaceutical Co., Ltd. (hereinafter referred to as...
Beijing Foyou Pharma(601089.SH) has announced that its wholly-owned subsidiary Fuyuan Pharmaceutical Co., Ltd. (referred to as "Fuyuan Pharmaceutical") recently received the Drug Registration Certificate for minoxidil solution (Specifications 1: 2% (60ml:1.2g), Specifications 2: 5% (60ml:3.0g), hereinafter referred to as "the drug") issued by the National Medical Products Administration (referred to as "NMPA") (Certificate Number: Specifications 1: 2025S00504, Specifications 2: 2025S00505).
The drug obtaining the Drug Registration Certificate will further enrich the company's product line and help enhance the company's product market competitiveness.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
